Bacteria Can Induce A Harmful Immune Response
Main Category: Immune System / VaccinesAlso Included In: Infectious Diseases / Bacteria / Viruses
Article Date: 17 Jun 2009 - 3:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Molecules known as type I IFNs are a central component of the protective immune response following infection with a virus. In contrast, these molecules are not normally linked to the protective immune response following infection with the bacterium Staphylococcus aureus, which is becoming a major health problem due to the emergence of methicillin-resistant (MRSA) strains. However, Alice Prince and colleagues have now determined that Staphylococcus aureus induce the production of type I IFNs by mouse and human airway cells, but these molecules are not part of a protective immune response in mice, rather they markedly enhance the severity of the pneumonia caused by Staphylococcus aureus infection.
In the study, the researchers were able to pin down the Staphylococcus aureus protein that causes mouse and human airway cells to produce type I IFNs, protein A. Further analysis identified the region of protein A responsible, the Xr domain, and determined the importance of the type I IFNs produced - mice lacking the molecule to which most type I IFNs bind were dramatically protected from lethal pneumonia caused by infection with Staphylococcus aureus. As the signaling pathway by which type I IFNs activate their effects is very well defined, the authors suggest that targeting molecules in this pathway might provide a beneficial therapeutic approach for treating pneumonia caused by Staphylococcus aureus infection.
TITLE: Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A
AUTHOR:
Alice Prince
Columbia University College of Physicians and Surgeons, New York, New York, USA.
View the PDF of this article at: https://www.the-jci.org/article.php?id=35879
Source:
Karen Honey
Journal of Clinical Investigation
JCI online early table of contents: June 15, 2009
Visit our immune system / vaccines section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/154156.php>
APA
http://www.medicalnewstoday.com/releases/154156.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



